Fresenius Kabi obtains FDA OK for biosimilar Tyenne
Biosimlar Tyenne is used in the treatment of several autoimmune diseases, including rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis.